Table 2.
Native folded substrates of ERAD, their subcellular localization and pathology.
| Substrates | Subcellular localization |
Cell type | Mouse model, phenotype and reference |
|---|---|---|---|
| Crebh | ER membrane, Nucleus | Hepatocytes |
Alb-cre; Sel1L
f/f, growth retardation, female fertility, Elevated Fgf21 levels (47) Alb-cre; Hrd1 f/f, growth retardation, female infertility, diurnal circadian behavior disruption, elevated circulating Fgf21 (48) Alb-cre; Hrd1 f/f, increased FA oxidation, TG lipolysis, lipophagy, and gluconeogenesis, impaired circadian profiles of circulating TG, FA and glucose (49) |
| Entpd5 Cpt2 Rmnd1 Hsd17b4 |
ER lumen Mitochondira Mitochondria Peroxisome |
Hepatocytes | Alb-cre/Mx1-cre; Hrd1 f/f, reduction of body weight, triglyceride, protect mice from HFD-induced obesity (50) |
| Acly | Cytosol | Hepatocytes | db/db mice injected with Hrd1 adenovirus, represses lipid synthesis, ameliorates systemic glycemic control and insulin sensitivity, attenuates steatosis (51) |
| Hnf1a Hnf4a |
Nucleus Nucleus |
Hepatocytes | Sel1L +/-, increased serum total bile acid concentrations (52) |
| Nrf2 | Nucleus | Hepatocytes | Hrd1 f/f mice are injected with Cre viruses, Suppression of anti-oxidation pathway, liver cirrhosis (53) |
| Wnt5a | ER lumen, secreted |
Hepatocytes | Alb-cre; Sel1L f/f, Alb-cre; Hrd1 f/f, are prone to developing chemically induced liver tumors, exhibit excessive proliferation following injury (54) |
| Pgc1β | Nucleus | adipocytes | CAG-Cre-ER; Hrd1 f/f, CAG-Cre-ER; Hrd1 f/f; ob/ob or db/db, Adiponectin-cre; Hrd1 f/f, weight loss and lower accumulation of white adipose tissue (55) |
| SigmaR1 | ER, cell membrane | adipocytes | Adiponectin or UCP1-cre; Sel1L f/f, Adiponectin or UCP1-cre; Hrd1 f/f, cold sensitive and exhibit mitochondrial dysfunction, affect ER-mitochondria contacts and mitochondrial dynamics (56) |
| Proinsulin | ER lumen, secreted |
Pancreatic β-cells | RIP-cre; Sel1L f/f, Ins1-cre; Sel1L f/f, reduced glucose-stimulated insulin secretion, hyperglycemia, glucose intolerance (57) |
| Tgfbr1 | Cell membrane | Pancreatic β-cells | Ins1-cre; Sel1L f/f, progressive hyperglycemia and glucose intolerance (58) |
| MafA | Nucleus | Pancreatic β-cells | db/db mice injected with AAV8-MIP-HRD1-GFP virus (59) |
| Ire1α | ER membrane | Enterocytes | Villin-cre; Sel1L f/f, susceptible to experimental colitis and inflammation-associated dysbiosis (60) |
| Gpat3 Dgat2 Mogat2 |
ER membrane | Enterocytes | Villin-cre; Aida f/f, HFD-induced obesity, increased fatty acid re-esterification and lipid absorption in intestine, postprandial hypertriglyceridemia (61) |
| Pomc | ER lumen, secreted |
POMC neurons | POMC-cre; Sel1L f/f, age-associated obesity and hyperleptinemia, hyperphagia, impaired leptin sensitivity (62) |
| Pro-Avp | ER lumen, secreted |
AVP-producing neurons | AVP-promoter driving cre; Sel1L f/f, central diabetes insipidus, intracellular ER retention of proAVP (63) |